Serum vitamin D concentration and prostate cancer risk: a nested case-control study

Jiyoung Ahn1, Ulrike Peters, Demetrius Albanes

  • 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, Bethesda, MD 20892, USA. Ahnj@mail.nih.gov

Summary

Higher vitamin D levels were not linked to lower prostate cancer risk. Instead, elevated serum 25-hydroxyvitamin D [25(OH)D] concentrations may increase the risk of aggressive prostate cancer.